Ganga Pharmaceuticals Closes Trading Window for Un-audited Results

Ganga Pharmaceuticals Ltd has announced the closure of its trading window for all designated persons from October 1, 2026. This closure is in preparation for the declaration of the company's un-audited financial results for the half-year ending September 30, 2026. The trading window is expected to reopen 48 hours after the official announcement of these financial results to the stock exchange, adhering to the company's code of conduct for preventing insider trading.